Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
Agency
National Institutes of Health
Posted
Oct 9, 2026
Due Date
Oct 13, 2028
Description
<p>The purpose of the Stimulating Access to Research in Residency Transition Scholar (StARRTS) K38 Career Development program is to retain and support clinician-investigators who have successfully completed the <a href="https://grants.nih.gov/grants/guide/rfa-files/rfa-hl-18-023.html">Stimulating Access to Research in Residency (StARR) R38 Program</a> (<a href="https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-012.html">RFA-HL-26-012</a> and previous NOFOs) as resident-investigators. Individuals who receive K38 grants described in this Notice of Funding Opportunity (NOFO) will be referred to as Transition Scholars. The intent of this NOFO is to provide Transition Scholars with opportunities for additional research and career development during subsequent clinical fellowships or early career faculty appointments (as defined in Section III. 3. Additional Information on Eligibility). It is anticipated that the StARRTS K38 program will provide a pathway to retain the newly-created pool of clinician-investigators generated through the StARR R38 program. Transition Scholars will receive support for continued research and career development opportunities in basic, clinical, and/or translational research, thereby providing enhanced potential to accelerate the transition to independent research careers.</p><p>This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.</p>
AI Summary
Estimated Funding: 10,804,000 | Award Ceiling: 6,444,000 | Agency: National Institutes of Health
Details
- Notice ID
- 359676
- Solicitation Number
- RFA-HL-27-010
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health